SB-204741

From WikiMD's WELLNESSPEDIA

SB-204741 is a drug that acts as a selective antagonist for the serotonin receptor subtype 5-HT2B. It has been used in scientific research to investigate the function of this receptor, and has been found to have a variety of effects in animal studies, such as reducing appetite and having anti-inflammatory effects.

Pharmacology[edit]

SB-204741 is a selective antagonist for the 5-HT2B receptor, meaning it blocks the action of serotonin at this receptor. This can have a variety of effects, as the 5-HT2B receptor is involved in many different physiological processes.

Mechanism of action[edit]

SB-204741 works by binding to the 5-HT2B receptor and preventing serotonin from activating it. This can reduce the effects of serotonin in the body, which can have a variety of effects depending on the specific physiological process involved.

Uses in research[edit]

SB-204741 has been used in scientific research to investigate the function of the 5-HT2B receptor. It has been found to have a variety of effects in animal studies, such as reducing appetite and having anti-inflammatory effects.

Side effects[edit]

As with any drug, SB-204741 can have side effects. These can vary depending on the dose and individual response to the drug. Some potential side effects include nausea, vomiting, and dizziness.

See also[edit]


Stub icon

This WikiMD article can only be edited by registered and verified editors. You can log in or register.

  • SB-204741
    SB-204741

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=SB-204741&oldid=6334682"